Ficolin-A enhances inhibition of the C-terminal 19 kDa region of merozoite surface protein-1 of plasmodium berghei using test in vivo

Iranian Journal of Parasitology

Volumn 8, Issue 1, 2013, Pages 33-39

  Chen, F ^a   Liu, Q ^b   Xue, Y ^c   Huang, Y H ^b   Huang, F Y ^b   Lin, Y ^b   Tan, G H ^b   Zhou, J ^d  

^a HUBEI UNIVERSITY   (China)

^b HAINAN MEDICAL UNIVERSITY   (China)

^c HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d Wuhan Tuberculosis Dispensary   (China)

Author keywords

Ficolin A; MSP119; Plasmodium berghei

Indexed keywords

FICOLIN; MEROZOITE SURFACE PROTEIN 1; PLASMID VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CONTROLLED STUDY; FEMALE; GENETIC RECOMBINATION; IMMUNIZATION; MALARIA; MORBIDITY; MORTALITY; MOUSE; NEWBORN; NONHUMAN; OPEN READING FRAME; PARASITE LOAD; PARASITEMIA; PLASMODIUM BERGHEI; SURVIVAL; WESTERN BLOTTING;

EID: 84875328150     PISSN: 17357020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Aregawi M, Cibulskis R, Otten M, Williams R, Dye C: World Malaria Report 2008. World Health Organization, Geneva 2008.
2. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science. 1996; 272;50-53.
3. Matsushita M, Fujita T. The role of ficolins in innate immunity. Immunobiology. 2002. 205;490-497.
4. Fujita T, Matsushita M, Endo Y. The lectincomplement pathway and its role in innate immunity and evolution. Immunol Rev. 2004; 198:185-202.
5. Taira S, Kodama N, Matsushita M, Fujita T. Opsonic function and concentration of human serum ficolin/P35. Fukushima J Med Sci. 2000; 46:13-23.
6. Kuraya M, Matsushita M, Endo Y, Thiel S, Fujita T. Expression of H-ficolin/Hakata antigen, mannose-binding lectin-associated serine protease (MASP)-1 and MASP-3 by human glioma cell line T98G. Int Immunol. 2003;15:109-117.
7. Pan Q, Chen H, Wang F, Jeza VT, Hou W, Zhao Y, Xiang T, Zhu Y, Endo Y, Fujita T, Zhang XL. L-ficolin binds to the glycoproteins hemagglutinin and neuraminidase and inhibits influenza A virus infection both in vitro and in vivo. J Innate Immun. 2012; 4(3):312-324.
8. Fujimori Y, Harumiya S, Fukumoto Y, Miura Y, Yagasaki K, Tachikawa H, Fujimoto D. Molecular cloning and characterization of mouse ficolin-A. Biochem Biophys Res Commun. 1998; 244:796-800.
9. Ohashi T, Erickson HP. Oligomeric structure and tissue distribution of ficolins from mouse, pig and human. Arch Biochem Biophys.1998; 360:223-232.
10. Liu Y, Endo Y, Homma S, Kanno K, Yaginuma H, Fujita T. FicolinA and ficolin B are expressed in distinct ontogenic patterns and cell types in the mouse. Mol Immunol. 2005; 42:1265-1273.
11. Endo Y, Nakazawa N, Iwaki D, Takahashi M, Matsushita M, Fujita T. Interactions of ficolin and mannose-binding lectin with fibrinogen/fibrin augment the lectin complement pathway. J Innate Immun. 2009; 2(1):33-42.
12. Facer C A and Tanner M. Clinical trials of malaria vaccines: progress and prospects. Adv. Parasitol. 1997;39:1-68.
13. Good M F. Towards a blood-stage vaccine for malaria: are we following all the leads? Nat Rev Immunol. 2001; 1:117-125.
14. Holder AA: The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria. Parasitology. 2009;136:1445-1456.
15. Blackman MJ, Heidrich HG, Donachie S, McBride JS, and Holder AA. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasioninhibiting antibodies. J Exp Med. 1990;172:379-382.
16. Daly TM, Long CA: A recombinant 15-kilo-dalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice. Infect Immun. 1993; 61:2462-2467.
17. Ogutu BR, Apollo OJ, McKinney D, Okoth W, Siangla J, Dubovsky F, Tucker K, Waitumbi JN, Diggs C, Wittes J, Malkin E, Leach A, Soisson LA, Milman JB, Otieno L, Holland CA, Polhemus M, Remich SA, Ockenhouse CF, Cohen J, Ballou WR, Martin SK, Angov E, Stewart VA, Lyon JA, Heppner DG, Withers MR; MSP-1 Malaria Vaccine Working Group. Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya. PLoS One. 2009;4:e4708.
18. Tian JH, Miller LH, Kaslow DC, Ahlers J, Good MF, Alling DW, Berzofsky JA, Kumar S. Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine. J Immunol. 1996; 157:1176-1183.
19. Hirunpetcharat C, Tian JH, Kaslow DC, van Rooijen N, Kumar S, Berzofsky JA, Miller LH, Good MF. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxylterminal fragment of the merozoite surface protein-1 (MSP119) of Plasmodium yoelii expressed in Saccharomyces cerevisiae. Correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells. J Immunol. 1997;159:3400-3411.
20. Good, M. F. Vaccine-induced immunity to malaria parasites and the need for novel strategies. Trends Parasitol. 2005;21:29-34.
21. Conroy A, Serghides L, Finney C, Owino SO, Kumar S, Gowda DC, Liles WC, Moore JM, Kain KC. C5a enhances dysregulated inflammatory and angiogenic responses to malaria in vitro: potential implications for placental malaria. PLoS One. 2009;4(3):e4953.
22. Solabomi A. Ogun, Laurence Dumon-Seignovert, Jean-Baptiste Marchand, Anthony A. Holder,1 and Fergal Hill. The Oligomerization Domain of C4-Binding Protein (C4bp) Acts as an Adjuvant, and the Fusion Protein Comprised of the 19-Kilodalton Merozoite Surface Protein 1 Fused with the Murine C4bp Domain Protects Mice against Malaria. Infec and Immun. 2008;76(8):3817-3823.